Treating Acute MI Patients With Aggrastat on Their Way to Hospital

Overview

Treating an AMI patient with ST elevation with Aggrastat in the ambulance on his or her way to the hospital.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 2012

Interventions

  • Drug: Tirofiban
    • pci

Clinical Trial Outcome Measures

Primary Measures

  • mortality
    • Time Frame: immidiately

Secondary Measures

  • TIMI flow
    • Time Frame: 24 hours
    • feeling better

Participating in This Clinical Trial

Inclusion Criteria

patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital Exclusion Criteria:

  • women less than 50 years old and 80 years old, bleeding tendency, stroke in the past

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • The Baruch Padeh Medical Center, Poriya
  • Provider of Information About this Clinical Study
    • Menachem Nahir, The baruch Padeh Medical center
  • Overall Official(s)
    • Menachem Naheer, Study Chair, The Baruch Padeh Medicel Center, Poriya, Tiberias, Israel
  • Overall Contact(s)
    • Yonathan Hasin, Professor, 97246652648, yhasin@poria.health.gov.il

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.